EDITOR/CME DIRECTOR
Neil Love, MD
ASSOCIATE
EDITORS
Richard Kaderman, PhD
Kathryn Ault Ziel, PhD
WRITERS
Lilliam Sklaver Poltorack
PharmD
Douglas Paley
CONTINUING EDUCATION
ADMINISTRATOR
FOR NURSING
Sally Bogert, RNC, WHCNP
CONTENT
VALIDATION
Margaret Peng
Ginelle Suarez
Erin Wall
DIRECTOR,
CREATIVE
AND COPY EDITING
Aura Herrmann
CREATIVE
MANAGER
Fernando
Rendina
|
GRAPHIC DESIGNERS
Jason
Cunnius
Shantia Daniel
SENIOR PRODUCTION
EDITOR
Alexis Oneca
TRAFFIC COORDINATOR
Tere Sosa
COPY
EDITORS
Dave Amber
Mary DiNunzio
Rosemary Hulce
Pat Morrissey/Havlin
Carol Peschke
Susan Petrone
PRODUCTION
MANAGER
Patricia Kappes
AUDIO
PRODUCTION
Frank Cesarano
TECHNICAL
SERVICES
Arly Ledezma
WEB
MASTER
John Ribeiro
|
CONTACT
INFORMATION:
Neil Love, MD
RESEARCH TO PRACTICE
One Biscayne Tower
2 South Biscayne Boulevard
Suite 3600
Miami, FL 33131
Fax: (305) 377-9998
Email: NLove@ResearchToPractice.net
FOR
CME INFORMATION:
Email: CME@ResearchToPractice.net
|
This program was supported by
education grants from Abraxis
Oncology, AstraZeneca Pharmaceuticals LP, Genentech
BioOncology and Genomic Health Inc.
The audio tapes, compact discs, Internet
content and accompanying printed material are
protected by copyright. No part of this program
may be reproduced or transmitted in any form
or by any means, electronic or mechanical,
including photocopying, recording or utilizing
any information storage and retrieval system,
without written permission from the copyright
owner.
The opinions expressed are those of the presenters
and are not to be construed as those of the
publisher or grantors.
Participants have an implied responsibility
to use the newly acquired information to enhance
patient outcomes and their own professional
development. The information presented in this
activity is not meant to serve as a guideline
for patient management.
Any procedures, medications or other courses
of diagnosis or treatment discussed or suggested
in this activity should not be used by clinicians
without evaluation of their patients’ conditions
and possible contraindications on dangers in
use, review of any applicable manufacturer's
product information and comparison with recommendations
of other authorities.
